Use of β-lactam/β-lactamase inhibitors for extended-spectrum-β-lactamase infections: defining the right patient population

Tamma , PranitaVillegas, María Virginia2020-07-152020-07-1520171098-6596https://hdl.handle.net/20.500.12495/3503application/pdfengUse of β-lactam/β-lactamase inhibitors for extended-spectrum-β-lactamase infections: defining the right patient populationArtículo de revistaBeta-LactamasInhibidores de beta-LactamasasCarbapenémicosESBLsBloodstream infectionNeutropeniahttps://doi.org/10.1128/AAC.01094-17instname:Universidad El Bosquereponame:Repositorio Institucional Universidad El Bosquehttps://repositorio.unbosque.edu.coUse of β-lactam/β-lactamase inhibitors for extended-spectrum-β-lactamase infections: defining the right patient populationAcceso abiertohttps://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessAcceso abierto2017-06-05